Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome.

NCT02527200 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT02527200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02527200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome.
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
November 9, 2015
Completion date
November 19, 2020
Enrollment
56 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

metabolism and nutrition disorder, obesity